NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 383 filers reported holding NEKTAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $210 | +32.9% | 169 | 0.0% | 0.00% | – |
| Q1 2024 | $158 | +66.3% | 169 | 0.0% | 0.00% | – |
| Q4 2023 | $95 | -78.8% | 169 | -77.5% | 0.00% | – |
| Q3 2023 | $448 | +3.5% | 752 | 0.0% | 0.00% | – |
| Q2 2023 | $433 | -9.4% | 752 | 0.0% | 0.00% | – |
| Q1 2023 | $478 | -92.9% | 752 | -74.6% | 0.00% | -100.0% |
| Q4 2022 | $6,699 | +67.5% | 2,964 | +157.5% | 0.00% | 0.0% |
| Q3 2022 | $4,000 | +33.3% | 1,151 | +56.0% | 0.00% | +100.0% |
| Q2 2022 | $3,000 | 0.0% | 738 | +36.4% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | – | 541 | +5911.1% | 0.00% | – |
| Q4 2021 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 9 | -80.9% | 0.00% | -100.0% |
| Q4 2019 | $1,000 | – | 47 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 47 | -33.8% | 0.00% | -100.0% |
| Q2 2019 | $2,000 | -87.5% | 71 | -71.4% | 0.00% | -66.7% |
| Q1 2019 | $16,000 | -48.4% | 248 | -74.3% | 0.00% | -78.6% |
| Q4 2018 | $31,000 | -50.8% | 966 | -7.6% | 0.01% | -46.2% |
| Q3 2018 | $63,000 | -32.3% | 1,045 | -45.7% | 0.03% | -33.3% |
| Q2 2018 | $93,000 | -58.3% | 1,924 | -8.6% | 0.04% | -57.6% |
| Q1 2018 | $223,000 | +60.4% | 2,104 | -10.1% | 0.09% | +64.3% |
| Q4 2017 | $139,000 | +189.6% | 2,341 | +15.9% | 0.06% | +115.4% |
| Q3 2017 | $48,000 | +118.2% | 2,020 | +75.3% | 0.03% | +116.7% |
| Q2 2017 | $22,000 | +37.5% | 1,152 | +61.1% | 0.01% | +33.3% |
| Q1 2017 | $16,000 | – | 715 | +7844.4% | 0.01% | – |
| Q4 2016 | $0 | – | 9 | -83.3% | 0.00% | – |
| Q3 2016 | $0 | – | 54 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 54 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 54 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 54 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |